Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael A. Schwarzschild, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Michael Schwarzschild and Alberto Ascherio.
Connection Strength

5.480
  1. Caffeinated clues and the promise of adenosine A(2A) antagonists in PD. Neurology. 2002 Apr 23; 58(8):1154-60.
    View in: PubMed
    Score: 0.259
  2. Urate and neuroprotection trials. Lancet Neurol. 2014 Aug; 13(8):758.
    View in: PubMed
    Score: 0.152
  3. Age, statin use, and the risk for incident Parkinson disease-reply. Arch Neurol. 2012 Oct 1; 69(10):1381.
    View in: PubMed
    Score: 0.134
  4. Age, statin use, and the risk for incident Parkinson disease-reply. Arch Neurol. 2012 Oct 01; 69(10):1381.
    View in: PubMed
    Score: 0.134
  5. Caffeine and risk of Parkinson's disease in a large cohort of men and women. Mov Disord. 2012 Sep 01; 27(10):1276-82.
    View in: PubMed
    Score: 0.133
  6. Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women. Mov Disord. 2012 Jul; 27(8):980-7.
    View in: PubMed
    Score: 0.131
  7. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology. 2012 Apr 10; 78(15):1138-45.
    View in: PubMed
    Score: 0.129
  8. Prospective study of statin use and risk of Parkinson disease. Arch Neurol. 2012 Mar; 69(3):380-4.
    View in: PubMed
    Score: 0.128
  9. Declining quality of life in Parkinson disease before and after diagnosis. J Parkinsons Dis. 2012; 2(2):153-60.
    View in: PubMed
    Score: 0.127
  10. Obesity, diabetes, and risk of Parkinson's disease. Mov Disord. 2011 Oct; 26(12):2253-9.
    View in: PubMed
    Score: 0.123
  11. A prospective study of bowel movement frequency and risk of Parkinson's disease. Am J Epidemiol. 2011 Sep 01; 174(5):546-51.
    View in: PubMed
    Score: 0.122
  12. Serum urate and probability of dopaminergic deficit in early "Parkinson's disease". Mov Disord. 2011 Aug 15; 26(10):1864-8.
    View in: PubMed
    Score: 0.121
  13. Use of ibuprofen and risk of Parkinson disease. Neurology. 2011 Mar 08; 76(10):863-9.
    View in: PubMed
    Score: 0.120
  14. Restless legs syndrome and Parkinson's disease in men. Mov Disord. 2010 Nov 15; 25(15):2654-7.
    View in: PubMed
    Score: 0.117
  15. Calcium channel blocker use and risk of Parkinson's disease. Mov Disord. 2010 Sep 15; 25(12):1818-22.
    View in: PubMed
    Score: 0.116
  16. Prenatal and early life factors and risk of Parkinson's disease. Mov Disord. 2010 Aug 15; 25(11):1560-7.
    View in: PubMed
    Score: 0.115
  17. Plasma urate and Parkinson's disease in women. Am J Epidemiol. 2010 Sep 15; 172(6):666-70.
    View in: PubMed
    Score: 0.115
  18. Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women. Parkinsonism Relat Disord. 2010 Jul; 16(6):370-5.
    View in: PubMed
    Score: 0.112
  19. Restless legs syndrome and erectile dysfunction. Sleep. 2010 Jan; 33(1):75-9.
    View in: PubMed
    Score: 0.110
  20. Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol. 2009 Dec; 66(12):1460-8.
    View in: PubMed
    Score: 0.110
  21. Family history of melanoma and Parkinson disease risk. Neurology. 2009 Oct 20; 73(16):1286-91.
    View in: PubMed
    Score: 0.109
  22. Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1359-65.
    View in: PubMed
    Score: 0.107
  23. Obesity and restless legs syndrome in men and women. Neurology. 2009 Apr 07; 72(14):1255-61.
    View in: PubMed
    Score: 0.105
  24. Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality. Am J Epidemiol. 2009 Mar 15; 169(6):678-82.
    View in: PubMed
    Score: 0.103
  25. Genetic determinants of hair color and Parkinson's disease risk. Ann Neurol. 2009 Jan; 65(1):76-82.
    View in: PubMed
    Score: 0.103
  26. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol. 2008 Jun; 65(6):716-23.
    View in: PubMed
    Score: 0.098
  27. Perceived imbalance and risk of Parkinson's disease. Mov Disord. 2008 Mar 15; 23(4):613-6.
    View in: PubMed
    Score: 0.097
  28. Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol. 2008 Apr 01; 167(7):831-8.
    View in: PubMed
    Score: 0.097
  29. Telomere length and risk of Parkinson's disease. Mov Disord. 2008 Jan 30; 23(2):302-5.
    View in: PubMed
    Score: 0.097
  30. Recreational physical activity and risk of Parkinson's disease. Mov Disord. 2008 Jan; 23(1):69-74.
    View in: PubMed
    Score: 0.096
  31. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007 Nov; 86(5):1486-94.
    View in: PubMed
    Score: 0.095
  32. Peripheral inflammatory biomarkers and risk of Parkinson's disease. Am J Epidemiol. 2008 Jan 01; 167(1):90-5.
    View in: PubMed
    Score: 0.094
  33. Erectile function and risk of Parkinson's disease. Am J Epidemiol. 2007 Dec 15; 166(12):1446-50.
    View in: PubMed
    Score: 0.094
  34. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology. 2007 Oct 23; 69(17):1688-95.
    View in: PubMed
    Score: 0.094
  35. Plasma urate and risk of Parkinson's disease. Am J Epidemiol. 2007 Sep 01; 166(5):561-7.
    View in: PubMed
    Score: 0.093
  36. Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology. 2007 Mar 06; 68(10):764-8.
    View in: PubMed
    Score: 0.091
  37. Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol. 2007 May 01; 165(9):998-1006.
    View in: PubMed
    Score: 0.090
  38. Pesticide exposure and risk for Parkinson's disease. Ann Neurol. 2006 Aug; 60(2):197-203.
    View in: PubMed
    Score: 0.087
  39. Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Mov Disord. 2006 Jul; 21(7):1002-7.
    View in: PubMed
    Score: 0.087
  40. A prospective study of night shift work, sleep duration, and risk of Parkinson's disease. Am J Epidemiol. 2006 Apr 15; 163(8):726-30.
    View in: PubMed
    Score: 0.084
  41. Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci. 2006 Jan 11; 26(2):535-41.
    View in: PubMed
    Score: 0.084
  42. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol. 2005 Dec; 58(6):963-7.
    View in: PubMed
    Score: 0.083
  43. Physical activity and the risk of Parkinson disease. Neurology. 2005 Feb 22; 64(4):664-9.
    View in: PubMed
    Score: 0.079
  44. Folate intake and risk of Parkinson's disease. Am J Epidemiol. 2004 Aug 15; 160(4):368-75.
    View in: PubMed
    Score: 0.076
  45. Obesity and the risk of Parkinson's disease. Am J Epidemiol. 2004 Mar 15; 159(6):547-55.
    View in: PubMed
    Score: 0.074
  46. Alcohol consumption and the incidence of Parkinson's disease. Ann Neurol. 2003 Aug; 54(2):170-5.
    View in: PubMed
    Score: 0.071
  47. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol. 2003 Aug; 60(8):1059-64.
    View in: PubMed
    Score: 0.071
  48. Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord. 2003 Jun; 18(6):646-51.
    View in: PubMed
    Score: 0.070
  49. Caffeine, postmenopausal estrogen, and risk of Parkinson's disease. Neurology. 2003 Mar 11; 60(5):790-5.
    View in: PubMed
    Score: 0.069
  50. Particulate matter and risk of Parkinson disease in a large prospective study of women. Environ Health. 2014 Oct 07; 13:80.
    View in: PubMed
    Score: 0.038
  51. Mendelian randomization of serum urate and parkinson disease progression. Ann Neurol. 2014 Dec; 76(6):862-8.
    View in: PubMed
    Score: 0.038
  52. A prospective analysis of airborne metal exposures and risk of Parkinson disease in the nurses' health study cohort. Environ Health Perspect. 2014 Sep; 122(9):933-8.
    View in: PubMed
    Score: 0.038
  53. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014 Feb; 71(2):141-50.
    View in: PubMed
    Score: 0.037
  54. Restless legs syndrome: an early clinical feature of Parkinson disease in men. Sleep. 2014 Feb 01; 37(2):369-72.
    View in: PubMed
    Score: 0.037
  55. Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease. Mov Disord. 2012 Sep 15; 27(11):1392-7.
    View in: PubMed
    Score: 0.033
  56. Serum cholesterol and the progression of Parkinson's disease: results from DATATOP. PLoS One. 2011; 6(8):e22854.
    View in: PubMed
    Score: 0.031
  57. Plasma urate and progression of mild cognitive impairment. Neurodegener Dis. 2009; 6(1-2):23-8.
    View in: PubMed
    Score: 0.025
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.